维普中文期刊产品整合服务
127篇 您的检索式:作者名="SALIBA M"
    题名 作者 年代 出处 被引量
1干扰素调节因子5通过损伤胞葬作用控制动脉粥样硬化病变中的坏死核心形成显示文摘髓系细胞是动脉粥样硬化病变发展和易损斑块形成的核心。动脉吞噬细胞吸收凋亡细胞(胞葬作用)的能力受损,可促进病变生长并建立坏死核心。干扰素调节因子(interferon regulatory factor,IRF)5是髓系细胞功能的重要调节因子。该研究试图确定IRF5是否影响动脉粥样硬化病变的形成和表型。方法:通过两种互补模型,研究IRF5在动脉粥样硬化中的作用:Seneviratne AN Edsfeldt AO Cole JE Kassiteridi C Swart M Park I Green P Khoyratty TE Saliba DG Goddard ME Sansom SN Goncalves I Krams R Udalova IA Monaco C 刘莉 叶鹏 2017中华高血压杂志2017,25,8:9
2Systemic lupus erythematosus and innammatory bowel disease 显示文摘NITZAN O ELIAS M SALIBA WR 2006Eur J Intern Med2006,17,5:1
3Higher energy synchronized external direct current cardioversion for refractory atrial fibrillation显示文摘Saliba W Juratli N Chung M K 1999J Am Coll Cardiol1999,34,7:1
4Atrial fibrillation ablation using a robotic catheter remote control system:initial human experience and long-term follow-up results显示文摘Saliba W Reddy VY Wazni O Cummings JE Burkhardt JD Haissaguerre M 0,,25:1
5Seasonal, diurnal and nocturnal behaviors of lower carbonyl compounds in the urban environment of Beirut, Lebanon 显示文摘Moussa S G El-Fadel M Saliba N A 2006Atmospheric Environment2006,40,14:1
6Allogeneic transplantation:a therapeutic option for myelofibrosis,chronic myelomonocytic leukemia and Philadelphia-negative/BCR-ABL-negative chronic myelogenous leukemia显示文摘Mittal P Saliba R M Giralt S A 2004Bone Marrow Transplant2004,33,10:1
7En- hancement of perovskite - based solar cells employing core- shell metal nanoparticles 显示文摘ZHANG Wei SALIBA M STRANKS S D 2013Nano Lett2013,13,:1
8The Vulnerable Elders Survey : a tool for identifying vulnerable older people in the community 显示文摘Saliba D Elliott M Rubenstein LZ 2001J Am Geriatr Soc2001,49,12:1
9Seasonal, diurnal and nocturnal behaviors of lower carbenyl compounds in the urban environment of Beirut, Lebanon 显示文摘Moussa S G El-Fadel M Saliba N A 2006Atmos Environ2006,40,:1
10Hemorrhagic cystitis after al- logeneic hematopoietic stem cell transplantation:donor type matters显示文摘El-Zimaity M Saliba R Chan K 2004Blood2004,103,:1
11Nonablative allogeneic hematopoietic transplantation as adoptive immunotherapy for indolent lymphoma;low incidence of toxicity,acute grafe-versushost disease and treatment related mortality显示文摘Khori I F Saliba R M Giralt S A 2001Blood2001,15,:1
12A phase Ⅲ study of infliximab and corticosteroids for the initial treatment of acute graft-versus-host disease 显示文摘Couriel DR Saliba R de Lima M 2009Biol Blood Marrow Transplant2009,15,12:1
13Development and validation of a prognostic score to predict mortality in patients with acute-on-chronic liver failure 显示文摘Jalan R Saliba F Pavesi M CANONIC study investigators of the EASL-CLIF Consortium 2014J Hepatol2014,61,5:1
14Enhancement of perovskite-based solar cells employing core-shell metal nanoparticles 显示文摘ZHANG W SALIBA M STRANKS S D 2013Nano Lett2013,13,9:1
15Sub 150 ℃ processed meso-superstructured perovskite solar cells with enhanced efficiency 显示文摘WOJCIECHOWSKI K SALIBA M LEIJTENS T et al 2014Energy Environ Sci2014,7,3:1
16The ubiquitin-like protein Plic-1enhances the membrane insertion of GABAA receptors byincreasing their stability within the endoplasmic reticulum显示文摘Saliba RS Pangalos M Moss SJ 2008JBiol Cftem2008,283,18:1
17Nonablative allo - geneic hematopoietic transplantation as adoptive immuno - therapy for indolent lymphoma;low incidence of toxicity, acute grafe - versus - host disease and treatment - related mortality 显示文摘Khori I F Saliba R M Giralt S A 2001Blood2001,15,:1
18Up regulation of Fas expression by Pseudomonas aeruginosa, infected endothelial cells depends on modulation of iNOS and enhanced production of NO induced by bacterial type Ⅲ secreted proteins 显示文摘ASSIS M C FREITAS C SALIBA A M 2006Inter J Mole Med2006,18,:1
19Prevalence of candida spin hospitalized patients and their risk factors显示文摘Resnde J C de Resende M A Saliba J L 2002Mgcoses2002,45,8:1
20Role of rpoS in Escherichia coli O157: H7 strain H32 biofilm development and survival 显示文摘Sheldon J R Yim M S Saliba J H 2012Applied and Environmental Microbiology2012,78,23:1
返回顶部 每页显示:
共7页 首页 上一页 第1页 下一页 末页 /7 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费